Middle East and Africa Iodinated Contrast Media in Interventional X-Ray Market – Industry Trends and Forecast to 2030

Analyse et taille du marché des produits de contraste iodés pour les radiographies interventionnelles au Moyen-Orient et en Afrique

Le marché des produits de contraste iodés pour les rayons X interventionnels au Moyen-Orient et en Afrique devrait connaître une croissance considérable au cours de la période de prévision. L'incidence de l'obésité chez les adultes de 30 à 60 ans en Arabie saoudite a augmenté de 1,5 % pour les femmes et de 4,1 % pour les hommes au cours de l'année entre 1992 et 2005. L'incidence des maladies chroniques avec comorbidités multiples est plus élevée chez les personnes âgées. La préférence croissante pour les produits de contraste iodés par rapport aux produits de contraste traditionnels augmente le marché au cours de la période de prévision 2023-2030.

Data Bridge Market Research analyse le taux de croissance du marché des produits de contraste iodés en radiographie interventionnelle au Moyen-Orient et en Afrique au cours de la période de prévision 2023-2030. Le TCAC attendu du marché des produits de contraste iodés en radiographie interventionnelle au Moyen-Orient et en Afrique a tendance à être d'environ 3,60 % au cours de la période de prévision mentionnée. La valeur du marché est de 3 654,3 millions USD en 2022 et elle atteindrait 4 849,4 millions USD d'ici 2030. En plus des informations sur le marché telles que la valeur du marché, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe de recherche sur le marché de Data Bridge comprend également une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Portée et segmentation du marché des produits de contraste iodés pour les examens radiographiques interventionnels au Moyen-Orient et en Afrique

Définition du marché

Les produits de contraste iodés utilisés dans les radiographies interventionnelles sont importants pour permettre aux professionnels de la santé de prendre des décisions cliniques et diagnostiques appropriées à de nombreux niveaux de services de soins de santé. Les produits de contraste iodés sont le type d'agents de contraste qui contiennent des atomes d'iode et qui sont utilisés pour les modalités d'imagerie basées sur les rayons X telles que la tomodensitométrie (TDM). Ils peuvent également être utilisés en fluoroscopie, en angiographie et en phlébographie, et même rarement en radiographie simple. Ils sont utilisés pour les procédures impliquant des rayons X, telles que la TDM, la coronarographie, l'angiographie, l'arthrographie, la myélographie et les études fluoroscopiques gastro-intestinales. Les agents de contraste au gadolinium sont utilisés pour les études d'IRM.

Dynamique du marché des produits de contraste iodés pour les examens radiographiques interventionnels au Moyen-Orient et en Afrique

Conducteurs

• Des progrès technologiques accrus

L'introduction croissante de solutions numériques qui aident à la gestion de l'injection d'agents de contraste devrait stimuler la croissance du marché. Par exemple, Guerbet a lancé Contrast&Care 2.0, une solution numérique qui connecte tous les injecteurs CT, Cath Laboratory et IRM et dispose de fonctionnalités de lecture intelligente et de connectivité, permettant aux utilisateurs de scanner et de lire les données sur leurs smartphones et ordinateurs. Ainsi, ce facteur stimule la croissance du marché.

• Augmentation du taux de comorbidités complexes

L’apparition croissante de comorbidités complexes et de maladies chroniques a entraîné une augmentation des tests d’imagerie diagnostique, qui impliquent l’échographie, les rayons X et les technologies d’imagerie avancées telles que l’IRM et la tomodensitométrie. Par exemple, GE Healthcare a reçu l’approbation de la FDA américaine pour Clariscan, un agent de contraste utilisé pour l’IRM macrocyclique en novembre 2019. Ces produits aident à identifier le besoin d’analyses périopératoires avant les interventions chirurgicales et le traitement dans les procédures interventionnelles, ce qui stimule encore la croissance du marché.

Opportunités

• Augmentation des maladies chroniques

The occurrence of chronic conditions with multiple comorbidities is higher among the elderly adults. The incidence of obesity in adults of 30–60 years in Saudi Arabia increased by 1.5% for women and 4.1% for men yearly between 1992 and 2005. In Qatar and Kuwait, 35% and 36% of male; and 45% and 48% of female adults were found to be obese. In Kuwait, around 21% of males and 18% of females aged 10–19 were obese. The increase in obesity in the middle east countries is likely to have substantively contributed to the increasing rate of diabetes prevalence with an annualized rate of change of 4% in Saudi Arabia and of 2% in Oman. Additionally, the frequency of people with diabetes has increased from 5.9% to 13.7% in this area during the forecast period. Therefore, this factor create more opportunity for the market growth.

• Increased Drug Approvals

Numerous FDA approval for iodinated contrast agent will also increase the commercialization of new iodinated products in the market. As a result, large number of approvals for iodinated agents will aid in the growth of iodinated contrast media in interventional X-Ray market. For instance, the Food and Drug Administration (FDA) approved GE Healthcare Visipaque (iodixanol) imaging agent in March 2017. Therefore, growing drug approvals boost the growth of the market.

Restraints/Challenges

• High Cost

The increased expenditure which is required for setting up these techniques hamper the market growth. Numerous market players make huge investment in manufacturing new and advanced machines to increase the process and in return the cost is increased. Thus, this factor impede the market growth.

This Middle East and Africa iodinated contrast media in interventional X-Ray market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa iodinated contrast media in interventional X-Ray market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Middle East and Africa Iodinated Contrast Media in Interventional X-Ray Market

During the pandemic, all diagnostic procedures except COVID diagnosis showed a dip in 2020 which largely affected the growth of the market. Diagnosis of heart diseases reduced by nearly two-thirds globally during the early months of the pandemic as countries and patients prioritized COVID-19. In the post pandemic era, the introduction of digital solutions for precise and effective management of contrast agent injection is projected to boost market growth. Numerous studies are showing the fatal effect of COVID on health that causes heart attacks and strokes; this might surge the market growth in the future.

Recent Developments

• In 2019, General Electric and Daiichi Sankyo Company participated into an agreement that Daiichi Sankyo to transfer the authorization of marketing rights for four diagnostic imaging agents in Japan to GE Healthcare. After the completion of this agreement, the company expand their diagnostic imaging agents in the Japan. This will help company to expand their business in the market.

Middle East and Africa Iodinated Contrast Media in Interventional X-Ray Market Scope

The Middle East and Africa iodinated contrast media in interventional X-Ray market is segmented on the basis of route of administration, indication, agent type, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Route of Administration

• Intravenous
• Oral
• Rectal
• Others

Indication

• Cardiology
• Neurology
• General Surgery
• Oncology
• Urology

Agent Type

• Non-Ionic
• Ionic

End User

• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Other

 Middle East and Africa Iodinated Contrast Media in Interventional X-Ray Market Regional Analysis/Insights

The Middle East and Africa iodinated contrast media in interventional X-Ray market is analysed and market size insights and trends are provided by route of administration, indication, agent type, end-user and distribution channel as referenced above.

The major countries covered in the Middle East and Africa iodinated contrast media in interventional X-Ray market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

UAE dominates the Middle East and Africa iodinated contrast media in interventional X-ray market because of strong healthcare infrastructure base and increased consumption of iodinated contrast media in interventional X-ray. The wide presence of well-established healthcare facilities and easy availability of advanced technologies along with high demand for diagnostic procedures due to disease screening initiatives and disease management in this region is anticipated to increase the number of inpatient examinations.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Middle East and Africa Iodinated Contrast Media in Interventional X-Ray Market Share Analysis

The Middle East and Africa iodinated contrast media in interventional X-Ray market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Middle East and Africa respiratory diagnostics market.

Key players operating in the Middle East and Africa iodinated contrast media in interventional X-Ray market include:

• Bayer AG (Germany)
• Iso-Tex Diagnostics, Inc. (U.S.)
• Bracco Diagnostic Inc. (Italy)
• Novalek Pharmaceuticals Pvt. Ltd. (India)
• TAEJOON PHARM (South Korea)
• Unijules Life Sciences Ltd (India)
• General Electric (U.S.)
• Guerbet (France)
• J.B.Pharma (India)

SKU-50699